A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

NCT06291415 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

NCT06721013 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

NCT04518475 ·Status: RECRUITING ·Phase: PHASE4

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

NCT05369208 ·Status: COMPLETED ·Phase: PHASE3

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

NCT07234019 ·Status: RECRUITING ·Phase: PHASE2

Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)

NCT06594146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

NCT06531018 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

NCT04949009 ·Status: UNKNOWN

Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)

NCT06838962 ·Status: RECRUITING ·Phase: PHASE2

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

NCT03951623 ·Status: COMPLETED ·Phase: PHASE1

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

NCT07710248 ·Status: RECRUITING ·Phase: PHASE2

TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years

NCT04890041 ·Status: RECRUITING ·Phase: NA

A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia

NCT05562882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

NCT02323178 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

NCT07007962 ·Status: RECRUITING ·Phase: PHASE3

Biologic Characterization of Patients With ITP

NCT05694325 ·Status: RECRUITING ·Phase: NA

Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia

NCT07278908 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

A Study of Zanubrutinib in Patients With ITP

NCT05279872 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

NCT05311930 ·Status: UNKNOWN ·Phase: PHASE4

Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia

NCT06281327 ·Status: RECRUITING ·Phase: PHASE2

Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

NCT07362238 ·Status: RECRUITING ·Phase: PHASE2

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

NCT07083739 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy

NCT07400250 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

NCT07315373 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.

NCT01101295 ·Status: UNKNOWN